BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14965695)

  • 1. Uterine metastasis from infiltrating ductal carcinoma of breast in a patient receiving tamoxifen.
    Meydanli MM; Karadag N; Ataoglu O; Kafkasli A
    Breast; 2002 Aug; 11(4):353-6. PubMed ID: 14965695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine metastasis from a heterologous metaplastic breast carcinoma simulating a primary uterine malignancy.
    Sinkre P; Milchgrub S; Miller DS; Albores-Saavedra J; Hameed A
    Gynecol Oncol; 2000 Apr; 77(1):216-8. PubMed ID: 10739717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast carcinoma presenting as endometrial cancer. A case report.
    Lallas TA; Taskin M; Calanog A; Shevchuk MM
    J Reprod Med; 1997 Feb; 42(2):121-3. PubMed ID: 9058349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis from breast carcinoma to a tamoxifen-related endometrial polyp.
    Acikalin MF; Oner U; Tekin B; Yavuz E; Cengiz O
    Gynecol Oncol; 2005 Jun; 97(3):946-8. PubMed ID: 15896832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of 19th year pulmonary metastasis after radical mastectomy for breast cancer].
    Dohba S; Kondoh M; Fujita H; Kinami S; Inoue T; Komura Y; Ii T; Takegawa S; Kiriyama M; Kojima Y; Kibe Y; Watanabe K
    Kyobu Geka; 2000 Dec; 53(13):1129-32. PubMed ID: 11127561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal uterine bleeding as a presentation of metastatic breast disease in a patient with advanced breast cancer on tamoxifen therapy.
    Famoriyo A; Sawant S; Banfield PJ
    Arch Gynecol Obstet; 2004 Nov; 270(3):192-3. PubMed ID: 14735373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal uterine bleeding as a presentation of metastatic breast disease in a patient with advanced breast cancer.
    Karvouni E; Papakonstantinou K; Dimopoulou C; Kairi-Vassilatou E; Hasiakos D; Gennatas CG; Kondi-Paphiti A
    Arch Gynecol Obstet; 2009 Feb; 279(2):199-201. PubMed ID: 18470523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer with synchronous massive metastasis in the uterine cervix: a case report and review of the literature.
    Bogliolo S; Morotti M; Valenzano Menada M; Fulcheri E; Musizzano Y; Casabona F
    Arch Gynecol Obstet; 2010 Apr; 281(4):769-73. PubMed ID: 19876639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal uterine bleeding as a presenting sign of metastasis to the endometrium in a patient with a history of cutaneous malignant melanoma.
    Berker B; Sertcelik A; Kaygusuz G; Unlu C; Ortac F
    Gynecol Oncol; 2004 Apr; 93(1):252-6. PubMed ID: 15047246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis of breast cancer to a uterine leiomyoma.
    Kondo NI; Yoshida S; Kajiyama H; Nagasaka T; Uematsu T
    Breast Cancer; 2009; 16(2):157-61. PubMed ID: 18751874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late solitary metastasis of cutaneous malignant melanoma presenting as abnormal uterine bleeding.
    Fambrini M; Andersson KL; Buccoliero AM; Pieralli A; Livi L; Marchionni M
    J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):731-4. PubMed ID: 18840192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic invasive lobular carcinoma of the breast to the endometrium presenting with abnormal uterine bleeding; Case report.
    Arif SH; Mohammed AA; Mohammed FR
    Ann Med Surg (Lond); 2020 Mar; 51():41-43. PubMed ID: 32071717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
    Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M; Ramoni A; Mueller-Holzner E; Marth C
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital tuberculosis in a tamoxifen-treated postmenopausal woman with breast cancer and bloody vaginal discharge.
    Neonakis I; Mantadakis E; Gitti Z; Mitrouska I; Manidakis LG; Maraki S; Samonis G
    Ann Clin Microbiol Antimicrob; 2006 Sep; 5():20. PubMed ID: 16948834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated cervical metastasis of breast cancer: a case report and literature review.
    Mousavi A; Karimi Zarchi M
    J Low Genit Tract Dis; 2007 Oct; 11(4):276-8. PubMed ID: 17917574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.